In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Comorbidities and cardiomyopathies - How to manage?
Session

Event : Heart Failure 2018

Topic : Chronic Heart Failure

  • Session type : Rapid Fire Abstracts
  • Date : 28 May 2018
  • Time : 10:30 - 12:00

13 presentations in this session

Microvascular complications in diabetes patients with heart failure and reduced ejection fraction

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : SL Kristensen (Copenhagen,DK)

The importance of measuring fractional flow reserve to improve the efficiency of endovascular treatment on left main bifurcation lesions

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : D Maximkin (Moscow,RU)

Characterization of plasmacytoid and myeloid dendritic cells in acute human and experimental myocarditis

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : R Pistulli (Muenster,DE)

Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome: A report from SCAAR

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : E Omerovic (Gothenburg,SE)

Waist-hip ratio and mortality in heart failure; contradicting the obesity paradox

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : K Streng (Groningen,NL)

Dilated cardiomyopathy with midrange ejection fraction at diagnosis: characterization and natural history

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : A Cannata (Trieste,IT)

Thromboembolic events in left ventricular non-compactation cardiomyopathy, are there any predictors?

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : N Craveiro (Carregal Do Sal,PT)

The Left atrial strain provide improved diagnostics for elevated filling pressures at rest and/or during exercise in heart failure patients

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : A Manouras (Stockholm,SE)

Exercise hemodynamic profile of patients with heart failure with preserved versus mid-range ejection fraction

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : AJ Rieth (Bad Nauheim,DE)

Imaging phenotypes of left-dominant arrhytmogenic cardiomyopathy and dilated cardiomyopathy - a comparative magnetic resonance study

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : R Eiros (Madrid,ES)

De novo mutation rate in patients with hypertrophic cardiomyopathy and left ventricular non-compaction.

Event : Heart Failure 2018

  • Session : Comorbidities and cardiomyopathies - How to manage?
  • Speaker : E Zaklyazminskaya (Moscow,RU)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are